Canada - English - Health Canada

astrazeneca canada inc - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents

Canada - English - Health Canada

apotex inc - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents

Canada - English - Health Canada

sandoz canada incorporated - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents

Canada - English - Health Canada

natco pharma (canada) inc - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents

Canada - English - Health Canada

jamp pharma corporation - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - gefitinib 250 mg - 250 mg

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - gefitinib - tablet, film coated - gefitinib 250 mg

Canada - English - Health Canada

auro pharma inc - gefitinib - tablet - 250mg - gefitinib 250mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - gefitinib 250 mg - film-coated tablet - gefitinib

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - gefitinib - carcinoma, non-small-cell lung - antineoplastic agents - iressa is indicated for the treatment of adult patients with locally advanced or metastatic non-small-cell lung cancer with activating mutations of epidermal-growth-factor-receptor tyrosine kinase.